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Abstract Two recent X-ray structures have tremendously in-
creased the understanding of the sarco/endoplasmic reticulum
Ca2+-ATPase (SERCA) and related proteins. Both structures
show the ¢fth transmembrane span (M5) as a single continuous
K-helix. The inherent structural and dynamic features of this
span (Lys758^Glu785) were studied in isolation in sodium do-
decyl sulfate (SDS) micelles using liquid-state nuclear magnetic
resonance (NMR) spectroscopy. We ¢nd that a £exible region
(Ile765^Asn768) is interrupting the K-helix. The location of the
£exible region near the Ca2+ binding residues Asn768 and
Glu771 suggests that together with a similar region in M6 it
has a hinge function that may be important for cooperative
Ca2+ binding and occlusion.
7 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Active cation transport across cell membranes as mediated
by P-type ATPases like Naþ,Kþ-ATPase and Ca2þ-ATPases
is of fundamental importance for cellular processes in eukary-
otic organisms, such as the formation of membrane potentials,
cell volume regulation, cotransport, muscle contraction, and
neurotransmission. This has motivated an enormous e¡ort to
understand the mechanistic function of these ATPases, start-
ing with the pivotal work of Skou on Naþ,Kþ-ATPase [1] and
Hasselbach on sarco/endoplasmic reticulum Ca2þ-ATPase
(SERCA) [2] in the ¢fties and sixties. These have been fol-
lowed by a large body of kinetic, mutagenesis, and topological
studies [3^8] and more detailed structural studies by electron
microscopy [9^11], X-ray di¡raction (XRD) [12^14], and nu-
clear magnetic resonance (NMR) spectroscopy [15^17].
Among the many P-type ATPases, the SERCA is the most
well-characterized system at the structural and functional lev-
el. SERCA has a molecular weight of 110 kDa distributed on
three large cytoplasmic domains and a membrane-bound do-
main, comprising 10 transmembrane helices as illustrated in
Fig. 1 using the XRD coordinates for Ca2þ-free SERCA de-
termined by Toyoshima et al. [14]. This 3.1 AA resolution XRD
structure, and an earlier 2.6 AA XRD structure for SERCA in
Ca2þ-bound form [13], form a unique basis for more detailed
functional analysis of mechanisms involved in the reaction
cycle. In short, the reaction cycle can be described by four
steps: E1CE1PCE2PCE2CE1, where E1 and E2 are the
two major conformational states and P indicates states phos-
phorylated by adenosine triphosphate (ATP). During the
E1PCE2P transition, Ca2þ is released from the high-a⁄nity
E1 states on the lumenal side of the membrane. However,
structural [12^14] and modelling [14,18] studies as well as
deductions made from the primary sequence [19], mutagenesis
[3,4,20,21] and biophysical experiments [22,23] reveal a large
separation between the ATP binding and phosphorylation
sites in the cytoplasmic domain and the Ca2þ binding sites
in the transmembrane domain. This has led to speculations
as to how conformational changes are transmitted between
the intra-membranous and cytosolic domains to enable the
ATPases (i) to become phosphorylated by ATP after cation
binding, and subsequent to phosphorylation (ii) to transport
cations through the membrane. Such changes will, in addition
to the proposed extensive movements of the cytosolic domains
in Ca2þ-ATPase [12,14] and Naþ,Kþ-ATPase [24,25], require
substantial £exibility of the highly conserved M4, M5, M6,
and M8 helices [4] which all contain residues involved in cat-
ion binding.
With respect to these issues, it should be borne in mind that
the XRD structures provide static snapshots of the E1 and E2
states, that the E2 state is stabilized by the potent inhibitor
thapsigargin and therefore not identical to the inhibitor-free
E2 state, and that the resolution (2.6 and 3.1 AA , respectively)
is not su⁄ciently high to fully characterize the details of local
structure. Focusing on the Ca2þ binding sites, it remains in-
teresting to study the structural £exibility in proximity of
critical residues such as Asn768, Gly770, and Glu771 in the
¢fth transmembrane segment M5, a segment extensively
studied by site-directed mutagenesis [3,5,26^30]. It is not un-
likely that structures with a £exible segment in the middle of
the membrane helix would be better suited for the structural
rearrangements required for Ca2þ binding and translocation
than the seemingly sti¡ K-helical structures revealed by XRD.
To examine these aspects, we have in this paper undertaken
a high-resolution NMR structural analysis of the isolated
Lys758^Glu785 (M5) membrane span in sodium dodecyl sul-
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fate (SDS) micelles. This study was motivated by the fact that
NMR is a very sensitive probe for local structure and £exi-
bility, although it is clear that the M5 segment is not in its
native environment and thus lacks the interactions with the
surrounding transmembrane helices. The usefulness of this
approach, however, is supported by the fact that previous
structural analysis of membrane segments of membrane pro-
teins such as bacteriorhodopsin [31^33], rhodopsin [34,35], F1-
F0-ATPase [36], and also previously the M6 segment of SER-
CA [15] in hydrophobic media proves to be in good agree-
ment with existing structures on membrane proteins [14,18,
37^39].
2. Materials and methods
2.1. Sample preparation
The 28-residue M5 peptide, acetyl-KQFIR YLISS NVGEV VSIFL
TAALG LPE-amide corresponding to Lys758^Glu785 of the ¢fth
membrane span of SERCA, was purchased from SynPep Corporation
(Dublin, CA, USA). The peptide was synthesized using Fmoc chem-
istry, with the N-terminal acetylated and the C-terminus blocked by
an amino group. The sequence was veri¢ed by mass spectrometry and
the purity was determined to be 95.5% by high-performance liquid
chromatography (HPLC). The M5 peptide was reconstituted into
fully deuterated SDS micelles by adding M5 peptide to a solution
containing 400 mM SDS-d25 (Cambridge Isotope Laboratories, An-
dover, MA, USA), 100 mM NaCl, 20 mM sodium phosphate (pH
7.0), 1 mM NaN3, and 10% D2O (90% H2O). The ¢nal peptide con-
centration was 2.4 mM.
2.2. NMR spectroscopy
All NMR spectra were recorded on a Bruker 600 MHz NMR spec-
trometer operating at a 1H frequency of 600.13 MHz (14.1 T). Phase-
sensitive (States-TPPI [40]) 1H double-quantum ¢ltered correlated
spectroscopy (DQF-COSY) [41,42], total correlation spectroscopy
(TOCSY) [43,44] (40 and 65 ms DIPSI-2 mixing [45]), and nuclear
Overhauser e¡ect spectroscopy (NOESY) [46,47] (100 and 170 ms
mixing) experiments were recorded at 313 K. The water signal was
suppressed using weak presaturation (2 s). All spectra were recorded
with a spectral width of 6361 Hz in both dimensions. Data matrices of
840U1024 points for the DQF-COSY spectra and 640U1024 points
for the TOCSY and NOESY spectra, respectively, were zero ¢lled to
1024U2048 points prior to Fourier transformation. The DQF-COSY
spectra were apodized using a sine window function shifted by Z/4 in
the t1 and Z/6 in the t2 dimension, respectively, while for the TOCSY
and NOESY spectra a cosine window function was applied in both
dimensions. All spectra were processed using the Bruker XWINNMR
software and analyzed using PRONTO [48].
2.3. Structure calculations
The secondary structure of the peptide was analyzed qualitatively
using 3JHNHK coupling constants extracted from the DQF-COSY
spectra, and 1HK chemical shift indices (CSI) [49,50]. Distance con-
straints were obtained from the 170 ms NOESY spectra using the
integration tool in PRONTO and categorized as strong (6 3.0 AA ),
medium (6 3.5 AA ), and weak (6 6.0 AA ). The spectra revealed 284
intra-residue, 127 sequential, and 153 medium range NOEs. The struc-
tures were calculated using the crystallography p NMR system (CNS)
[51], starting with extended structures [52], and using the torsion angle
dynamics (TAD) procedure [53] with NOE scale factors of 200, 200,
200, and 100 and temperature steps of 50 and 10 K in the ¢rst and
second slow-cooling periods, respectively. 50 structures were gener-
ated of which the 40 with lowest energy were selected for analysis.
These structures had no NOE violations s 0.2 AA , and analysis by
PROCHECK [54,55] showed that backbone torsion angles for
78.9%, 19.7%, 0.8%, and 0.7% of the residues are in the ‘most fa-
vored’, ‘additional allowed’, ‘generously allowed’, and ‘disallowed’
regions respectively. Root-mean-square deviation (RMSD) calcula-
tions and superposition were performed using MOLMOL [56]. The
secondary structure of the peptide was also predicted from the amino
acid sequence using the Rost and Sander procedure available on the
Protein Predict Server [57].
3. Results
Combination of data from the DQF-COSY, TOCSY, and
NOESY experiments allowed assignment of all 1H resonances
using the procedures of Wu«thrich [58]. To illustrate the qual-
ity of the spectra, Fig. 2 shows selected regions of the two-
dimensional (2D) NOESY spectrum. The many strong HN^
HN correlations indicate a helical conformation in at least
part of the peptide. This interpretation is further supported
by the full NOE connectivity pattern, the distribution of intra-
and inter-residue NOEs, 3JHNHK coupling constants, and HK
CSI, as summarized in Fig. 3A^C. The NOE pattern (Fig. 3A)
and distribution (Fig. 3D) indicate two K-helical regions ex-
tending over Lys758^Leu764 and Val769^Ala779 through the
presence of a large number of dKN(i,i+3) and dKL(i,i+3) corre-
lations in these regions. The 3JHNHK coupling constants are
indicative of K-helical structures in the Lys758^Ile765 and
Val769^Leu781 regions (Fig. 3B). The CSI method, where
the 1HK chemical shifts are compared with random coil val-
ues, suggests slightly shorter K-helices extending over Ile761^
Leu764 and Glu771^Thr778 (Fig. 3C). The sequence analysis
from the Protein Predict Server [57] generally agrees with the
NMR data, with K-helices being predicted for Gln759^Ser766
and Val769^Ala780 (Fig. 3E).
Confronted with the fact that two protons only need to be
in close contact part of the time to give a signi¢cant NOE
cross-peak, it is relevant to estimate the helical content on
basis of the 3JHNHK coupling constants as described by Brad-
ley et al. [59]. The measured coupling constants 3JHNHK are
compared with a typical random coil coupling constant,
3Jrc = 8 Hz, and K-helical coupling constant, 3Jhelix = 4 Hz,
to calculate the overall helical content as (3JHNHK33Jrc)/
(3Jhelix33Jrc). For Lys758^Ile765 and Val769^Leu781 a con-
servative estimate is a helical population above 50%.
Fig. 1. The XRD structure of Ca2þ-free SERCA (Protein Data
Bank, PDB, code 1IWO) [14] with the 28-residue M5 peptide repre-
sented in ribbon form.
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Since an uninterrupted and rather rigid K-helical structure
is expected from the XRD structures of Toyoshima and co-
workers [13,14], it is relevant to address speci¢c attention to
the intermediate £exible region. This region shows typical
random coil 3JHNHK couplings and chemical shifts, and lacks
the medium range NOEs typical of ordered structure, as is
clearly shown when overlaying the 40 lowest energy structures
(Fig. 4). The structures are all largely K-helical, but the rela-
tive orientation of the two helical segments varies from struc-
ture to structure. As illustrated in Fig. 3F, superposition of
the full peptide results in an averaged backbone RMSD of
2.8 AA , which compares unfavorably with typical values of
Fig. 2. Selected regions of the 170 ms 2D NOESY spectrum of the M5 peptide in SDS micelles. A: Fingerprint HK^HN region. B: Amide HN^
HN region. For clarity, only NOEs between non-neighboring residues are shown in A.
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0.3^0.6 AA for K-helices in globular proteins. Superposition of
the peptides con¢ned to either of the established helical re-
gions, Phe760^Leu764 and Val769^Ala780, leads to the much
lower backbone RMSD values of 0.15 AA and 0.16 AA , respec-
tively. The localization of structure and disorder is also illus-
trated by the backbone torsion angles of the 40 lowest energy
structures as shown in Fig. 3G. Disordered regions are also
found in the N- and C-termini (Lys758^Gln759 and Leu781^
Glu785, respectively), starting near the limits of the expected
membrane spanning segment. However, although the last ¢ve
C-terminal residues show signi¢cant disorder, NMR structure
backbone torsion angles follow a pattern that is similar to
what is seen in the XRD structures, indicating that the struc-
tural feature of the full protein is retained also near an arti-
¢cial ending in an aqueous environment.
4. Discussion
The ¢nding that the transmembrane part of the SERCA
M5 helix contains a £exible hinge region near Asn768 and
Glu771 in membrane-like environments is interesting for sev-
eral reasons. It o¡ers new perspectives on the structural in-
formation from the recent XRD studies [13,14], which show
Fig. 3. Summary of structural parameters for M5 in SDS micelles.
The peptide sequence with the putative Ca2þ binding sites indicated
with black squares is shown in the top. A: Sequential and medium
range NOEs with thicker lines indicating higher NOE intensity, and
asterisks indicating NOEs that can not be unambiguously identi¢ed
due to overlap with other signals. B: 3JHNHK coupling constants
with ¢lled circles, open circles, and ¢lled triangles (non-glycine resi-
dues) representing coupling constants less than 5 Hz, less than 6 Hz,
and above 8 Hz, respectively. C: 1HK CSI using random coil values
from [50]. D: NOE distribution with white, shaded, and black bars
representing intra-residual, sequential, and medium range NOEs, re-
spectively. E: Helix propensities (indicated by H) obtained using the
Protein Predict Server [57]. F: RMSD values for MOLMOL align-
ment of the 40 best structures in the regions Phe760^Leu764 (dot-
dashed line), Val769^Ala780 (solid line), and the full peptide
(dashed line). G: P and i backbone torsion angles with the bars
showing the distribution (standard deviations) over the 40 analyzed
NMR structures (black circles), and the P and i backbone torsion
angles for the XRD structures of the Ca2þ-bound E1 form (PDB
code: 1EUL; dashed line) [13] and the Ca2þ-free E2 form (PDB
code: 1IWQ; dot-dashed line) [14].
Fig. 4. Superposition of the 40 lowest-energy structures calculated
for the M5 transmembrane peptide using (A) residues Val769 to
Ala780 and (B) Phe760 to Leu764. Residues Lys758 to Glu785 (A)
and Lys758 to Asn768 (B) are shown.
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one straight K-helix, and adds structural evidence related to
earlier mutagenesis- and modelling-based models on Ca2þ
binding/release in SERCA [3,5^7,20,26^29,60]. Along with
Thr799 and Asp800 (in M6) and Glu908 (in M8), Asp768
and Glu771 are considered strong candidates as donors of
oxygen ligands for Ca2þ binding in the ¢rst binding site (I),
while Glu309 in M4 and Asn796 and Asp800 in M6 together
with the carbonyl oxygens of Val304, Ala305, and Ile307 in
M4 act as donors to Ca2þ binding at site II [13,14]. A crucial
role of Glu771, together with Thr799 and Asp800 is empha-
sized by mutation experiments which indicate that these resi-
dues are necessary not only for Ca2þ binding at site I, but also
for cooperative interaction between the two Ca2þ sites
[6,7,27,29,60]. It has been suggested that in the Ca2þ-free E2
form the Ser767 and Asn768 sidechains may be involved in
hydrogen bonding to the carboxyl groups in the Ca2þ-ligating
Glu771 and Asp800 residues [14]. In addition, site-directed
mutagenesis has revealed that Gly770 together with Gly310
and Gly801, all of which are located next to the glutamic and
aspartic Ca2þ ligands in M4, M5, and M6, are important for
Ca2þ binding and dissociation [27]. Substitution of these gly-
cines by amino acids with bulky sidechains [27] had a dramat-
ic negative e¡ect on the Ca2þ a⁄nity, which indicates either
that £exibility in proximity of the carboxylic residues is re-
quired for the Ca2þ binding and occlusion mechanism, or that
the Ca2þ transport is sterically hindered by a bulkier side-
chain. In this context it is of interest to note that, as ¢rst
noted by Rice and MacLennan [29], the putative calcium
binding M4, M5, and M6 helices all share the same sequence
motif Asp/Glu Gly Leu/Val (reversed in M5), located approx-
imately in the center of the membrane spanning segment, and
that the helices are interrupted in M4 and M6 [13,15]. Finally,
addressing the shorter N-terminal helix Phe760^Leu764, there
is evidence that substitution of Tyr763 by Gly uncouples the
Ca2þ transport from the Ca2þ-activated ATP hydrolysis [61].
This could indicate that a rotation of this helix with the bulky
tyrosine sidechain, relative to the C-terminal part of the M5
segment, is involved in the gating of Ca2þ in£ux from the
cytosolic side as suggested previously [3].
Taken together, most of the previous models appear com-
patible with the present NMR structure, which shows £exibil-
ity in the central Leu764^Asn768 region. This £exibility may
account for movements required to establish the necessary
coordination for Ca2þ binding and occlusion as well as the
hydrogen bonding interactions needed to stabilize the struc-
ture in the di¡erent states. While the XRD structures of SER-
CA [13,14] appear to be compatible with the £exible hinge in
M6 found in an earlier liquid-state NMR study of this seg-
ment in micelles [15], they have not revealed a similar £exi-
bility for the transmembrane part of M5. Instead this segment
is presented as a largely straight K-helix in the E1 state [13],
and an K-helix which is slightly curved in the cytosolic exten-
sion of M5 into S5 in the E2 state [14]. However, an increase
in the B factors for Ile765^Glu771 for the Ca2þ-free E2 state
[14] could suggest some mobility in this region. For illustra-
tion Fig. 5A shows the entire backbone of the M5/S5 helix
from both XRD structures in a ribbon mode. The larger
structural £exibility o¡ered by the NMR structure is illus-
trated in Fig. 5B, where the three lowest energy structures
are compared to the XRD structures. While this £exibility
may appear surprising relative to the XRD structure, it should
be noted that secondary structure prediction calculations are
in support of the presence of hinge regions in the membrane
center of M5 as well as in the N-terminal cytoplasmic bound-
ary region. Clearly, there is very good agreement between the
XRD and NMR structures in the C-terminal Gly770^Ala780
part of M5, which in both cases is described as an amphi-
phatic helix with a hydrophilic/charge lining composed of
Glu770, Ser774, and Thr778 on one side of an overall hydro-
phobic surface. It should be noted that the large variation in
the bend angle of the hinge shown for the NMR structures is
likely to be a consequence of lack of structurally ordered
protein context and incorporation in a micellar non-ordered
environment, and that the degree of £exibility in this region
may be altered within the context of the full molecule.
It is interesting to note that the £exible region Leu764^
Asn768 of M5, as revealed here, has a very similar location
in the membrane compared to the £exible region Thr799^
Asp800 in M6, in support of the presence of a £exible Ca2þ
binding cavity between the helices M4, M5, and M6 [15].
Flexibility may also have consequences for the details of the
conformational changes occurring during the Ca2þ-ATPase
cycle. Thus, it has been proposed that rotation of the sti¡
M5 membrane span around a pivotal point close to Gly770
is important for coupling motions in the membrane Ca2þ
binding site and the cytoplasmic phosphorylation site associ-
ated with the E1 to E2 transition [14]. Indeed, the evidence of
£exibility for certain regions of the M5/S5 helix provided by
our study can be seen as support for the bending of the chain
which has been described especially in the E2 state [14]. Here
we note that the degree of £exibility is likely to depend on the
presence of bound Ca2þ and the actual state in the cycle. The
ordered helical structure for this segment described in the E1
structure [13], together with an increase in the B factors of the
hinge in the E2 structure [14], suggests that this indeed is the
Fig. 5. Ribbon representation of (A) the full M5 helix (Asn739^
Glu785) determined by Toyoshima et al. for the Ca2þ-bound E1
form (PDB code: 1EUL) [13] and the Ca2þ-free E2 form (PDB
code: 1IWQ) [14] and (B) superposition of the three best NMR
structures in a ribbon representation aligned with the XRD struc-
tures in a line representation. All structures were aligned using the
Val769^Ala780 region.
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case. A relatively sti¡ state of the M5/S5 helix in the E1 state
may also provide a structural basis for the linkage between
Ca2þ binding and phosphorylation by ATP present under
these conditions, e.g. by charge transduction through a series
of hydrogen bonds in continuous K-helices as has been re-
cently proposed [30]. Deeper insight into the detailed structure
and dynamics of active Ca2þ transport by SERCA may be
obtained in studies of larger fragments of the membrane do-
main, using liquid-state NMR techniques and solid-state
NMR on oriented samples [62,63], giving details on structure
and dynamics, of e.g. a signi¢cant part of a Ca2þ site, in a
micelle system, as well as the conformation and orientation in
a phospholipid bilayer membrane.
5. Supporting material
1H chemical shifts for M5 in SDS micelles have been de-
posited in the BioMagResBank (BMRB accession code 5765).
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